10x Insights
Loading account…
Companies / Materials / Solesence, Inc.
SLSN

Solesence, Inc.

MaterialsPersonal Care
Ticker SLSNROMEOVILLE, ILFiscal year ends DecemberBook value per share $0.19Diluted shares 70.6M

Solésence, Inc. (Nasdaq: SLSN) develops and manufactures skin health products and engineered materials for beauty, health, and wellness brands. Its consumer products include finished skin care, sun care, and color cosmetics formulations built around proprietary Active Stress Defense™ technologies, sold to brand… From the company’s description.

Over the twelve months to Jun 30, 2026, Solesence, Inc. reported revenue of $55.37M, down 14.0% from a year earlier, and a net loss of $2.08M. Its operating margin was −2.1%, and operations generated $1.02M in cash. In fiscal 2025, it reported revenue of $62.06M, up 18.6% from fiscal 2024, and net income of $1.79M.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$62.06MFY2025
+18.6% year over year
Last 12 mo $55.37M
2.53%FY2025
−7.3 percentage points
Last 12 mo -2.12%
$1.79MFY2025
−57.7% year over year
Last 12 mo $-2.08M
10.15%FY2025
−18.2 percentage points
Last 12 mo -15.79%
Cash & financing
$-8.57MFY2025
−534.7% year over year
Last 12 mo $1.02M
$-8.57MFY2025
−231.2% year over year
Last 12 mo $1.02M
0.87FY2025
Was 0.33× a year earlier
Last 12 mo 1.09
72.6MFY2025
+11.6% year over year
Last 12 mo 70.6M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Solesence, Inc. does

In the company’s own words

Solésence, Inc. (Nasdaq: SLSN) develops and manufactures skin health products and engineered materials for beauty, health, and wellness brands. Its consumer products include finished skin care, sun care, and color cosmetics formulations built around proprietary Active Stress Defense™ technologies, sold to brand partners for marketing under their own names rather than directly to consumers. The company also makes surface-engineered zinc oxide and titanium dioxide active pharmaceutical ingredients for sunscreen and other personal care manufacturers, including products supplied through a long-term relationship with BASF. Legacy advanced materials serve applications such as medical diagnostics, coatings, and plastics. Solésence operates as one business segment, with consumer products generating $54.9 million, or 88% of revenue, in fiscal 2025. Total revenue was $62.1 million that year, and the company had 115 full-time employees at year-end, in addition to demand-driven temporary staff. Formerly Nanophase Technologies Corporation, it adopted the Solésence name in 2025 as it shifted its focus toward finished consumer products. Its website is solesence.com.

Company details
Sector
Materials
Industry (SIC)
Personal Care
Headquarters
ROMEOVILLE, IL
Fiscal year end
December
CIK
883107
SIC
2844

Financial performance, year by year

Fiscal 2011–2025 · USD
$-11.04M$8.90M$28.84M$48.77M$68.71M201120122013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Solesence, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

44
funds hold it
0 of 35
superinvestors hold it
$1.51M
held by funds, at market
2.3%
of shares held by funds

Largest fund holders · Solesence, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Small Cap Index Fund
FSSNX · Fidelity Salem Street Trust
—of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD RUSSELL 2000 INDEX FUND
VTWO · VANGUARD SCOTTSDALE FUNDS
—of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
—of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Solesence, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Solesence, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Solesence, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.